{"id":"W4310161266","doi":"10.1182/blood-2022-166854","title":"Magnetismm-4: An Open Label, Phase 1B/2 Umbrella Study of Elranatamab in Combination with Other Anti-Cancer Treatments for Patients with Multiple Myeloma","year":2022,"lang":"en","type":"article","venue":"Blood","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":16,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"","keywords":"Multiple myeloma; Medicine; Cancer; Internal medicine; Open label; Oncology; Clinical trial","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":false,"about_ca":true,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004180124,0.003331177,0.003115331,0.001369488,0.001069375,0.001585859,0.002232557,0.002814268,0.008925891],"category_scores_gemma":[0.001446256,0.001347333,0.002319855,0.000765273,0.001552191,0.001759641,0.0008879408,0.005074593,0.002583918],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002249466,"about_ca_system_score_gemma":0.002835089,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001334077,"about_ca_topic_score_gemma":0.004182381,"domain_scores_codex":[0.9986191,0.0007392572,0.00005447186,0.0001963044,0.0001464681,0.0002443707],"domain_scores_gemma":[0.9990397,0.00008805771,0.0001828484,0.00009227532,0.00006433359,0.0005327552],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.6927779,0.1599803,0.004623599,0.001278891,0.001638747,0.0003230293,0.0002559107,0.001392248,0.05034326,0.0004647015,0.007178292,0.07974312],"study_design_scores_gemma":[0.7474573,0.2377599,0.005491095,0.00004923152,0.0005399474,0.0002197492,0.0000412068,0.0006666976,0.002618029,0.0002458718,0.004872104,0.00003890558],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9574559,0.00769589,0.00174236,0.002913801,0.0006138864,0.01751264,0.004837951,0.000559092,0.006668662],"genre_scores_gemma":[0.9298458,0.006053587,0.008993823,0.005855979,0.001121861,0.02482948,0.008506654,0.0001613523,0.0146315],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008925891,"threshold_uncertainty_score":0.02986008,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04226042840478516,"score_gpt":0.3533690573870865,"score_spread":0.3111086289823013,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}